Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Blue Bird Corporation - Common Stock
(NQ:
BLBD
)
56.74
-0.60 (-1.05%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Blue Bird Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
12 Industrials Stocks Moving In Wednesday's After-Market Session
↗
May 08, 2024
Via
Benzinga
Blue Bird Reports Fiscal 2024 Second Quarter Record Results; Raises 2024 Guidance and Long-Term Outlook
May 08, 2024
From
Blue Bird Corporation
Via
Business Wire
Trinity Stock Pops Nearly14%, Reports Massive Earnings Growth
↗
May 02, 2024
A Relative Strength Rating upgrade for Trinity Industries shows improving technical performance.
Via
Investor's Business Daily
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
↗
May 01, 2024
Via
Benzinga
Blue Bird Extends Exclusive Clean School Bus Collaboration with Ford Component Sales and ROUSH CleanTech to 2030
May 01, 2024
From
Blue Bird Corporation
Via
Business Wire
Deep Dive Into Blue Bird Stock: Analyst Perspectives (5 Ratings)
↗
April 23, 2024
Via
Benzinga
3 Obscure Stocks That Could Revolutionize Your Returns
↗
April 29, 2024
Investors mostly pay close attention to popular stocks. But, there are also strong stocks with low trading volume available.
Via
InvestorPlace
Blue Bird to Report Fiscal 2024 Second Quarter Results on May 8, 2024
April 24, 2024
From
Blue Bird Corporation
Via
Business Wire
Should you consider BLUE BIRD CORP (NASDAQ:BLBD) for growth investing?
↗
April 17, 2024
Why the growth investor may take a look at BLUE BIRD CORP (NASDAQ:BLBD).
Via
Chartmill
Looking for growth without the hefty price tag? Consider NASDAQ:BLBD.
↗
April 16, 2024
While growth is established for BLUE BIRD CORP (NASDAQ:BLBD), the stock's valuation remains reasonable.
Via
Chartmill
Ahead of the Curve: 7 Stocks to Buy Before They Go Mainstream
↗
April 10, 2024
Discover seven overlooked stocks to buy poised for 10X returns across diverse industries. Unlock their growth potential now.
Via
InvestorPlace
Is NASDAQ:BLBD suited for growth investing?
↗
March 26, 2024
High growth, ROE and beating expectations for NASDAQ:BLBD: growth investors may appreciate this.
Via
Chartmill
NASDAQ:BLBD, a growth stock which is not overvalued.
↗
March 26, 2024
BLUE BIRD CORP (NASDAQ:BLBD), a growth stock which is not overvalued.
Via
Chartmill
Is NASDAQ:BLBD a Fit for Growth Investing Strategies?
↗
March 05, 2024
Why BLUE BIRD CORP (NASDAQ:BLBD) qualifies as a high growth stock.
Via
Chartmill
NASDAQ:BLBD is not too expensive for the growth it is showing.
↗
March 05, 2024
BLUE BIRD CORP (NASDAQ:BLBD) stands out as a growth opportunity that won't break the bank.
Via
Chartmill
Despite its impressive fundamentals, NASDAQ:BLBD remains undervalued.
↗
April 08, 2024
Investors should take notice ofBLUE BIRD CORP (NASDAQ:BLBD)—it offers a great deal for the fundamentals it presents.
Via
Chartmill
Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Wednesday Morning
April 03, 2024
Via
Investor Brand Network
Topics
Energy
Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Thursday Morning
March 28, 2024
Via
Investor Brand Network
Topics
Energy
7 EV Stocks That Could Be Multibaggers in the Making: March Edition
↗
March 26, 2024
Discover EV stocks poised for explosive growth, tapping into cutting-edge technology and market dominance.
Via
InvestorPlace
3 Promising Small-Cap Stocks Packing a Powerful Punch
↗
March 23, 2024
Here're three under-the-radar small-cap stocks with robust growth potential that could deliver outsized returns for risk-tolerant investors.
Via
InvestorPlace
What 4 Analyst Ratings Have To Say About Blue Bird
↗
February 29, 2024
Via
Benzinga
Beat Wall Street: 3 Stocks Flying Under the Radar
↗
March 05, 2024
The market is full of many companies that most people haven’t even heard of. Add these stocks to your portfolio that fly under the radar.
Via
InvestorPlace
Blue Bird Corp. (NASDAQ: BLBD) Sets New 52-Week High in Friday Session
March 01, 2024
Via
Investor Brand Network
Topics
Energy
7 Must-Buy Stocks for a Diversified High-Growth Portfolio
↗
March 01, 2024
Explore how these high-growth portfolio stocks can drive substantial returns in IT, communication, industrials, and financials.
Via
InvestorPlace
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
February 27, 2024
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...
Via
Newsfile
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approv
Via
MarketBeat
Topics
Artificial Intelligence
Wall Street Favorites: 3 EV Stocks With Strong Buy Ratings for February 2024
↗
February 23, 2024
Though the certainty of the electric vehicle industry may be waning, these three EV stocks offer strong potential nonetheless.
Via
InvestorPlace
Topics
Electric Vehicles
3 Goliath Growth Stocks Poised for Takeoff in February
↗
February 19, 2024
These three top-tier growth stocks to buy offer investors incredible potential returns and are perfect for long-term investing.
Via
InvestorPlace
Blue Bird Announces Launch of Secondary Public Offering
February 15, 2024
From
Blue Bird Corporation
Via
Business Wire
Gene therapy: Why does it cost millions for a single treatment?
February 15, 2024
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology.
Via
MarketBeat
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today